This communication from StockBurger LLC contains both editorial content and paid advertisements. Some of the companies featured in our articles and newsletters may have compensated StockBurger LLC for promotional services. Advertorials are specifically marked as such to inform readers that the content is paid for by the sponsoring company.

Paid Promotion for Mainz Biomed N.V. (Nasdaq: MYNZ)

Currently, Mainz Biomed N.V. Ordinary Shares (Nasdaq: MYNZ) is part of a paid promotional campaign on our platform. StockBurger LLC has been compensated $300,000 by Mainz Biomed N.V. for marketing and promotional services related to this communication. The compensation received may influence the presentation, content, and messaging about this company. StockBurger LLC does not own any shares of Mainz Biomed N.V. (MYNZ), and any statements made regarding the company are for informational and promotional purposes only, not based on any financial interest in the company.

Editorial Independence and Disclosure of Compensation

While StockBurger LLC maintains editorial independence, content labeled as advertorial may include positive commentary or strategic focus areas determined by the company’s sponsorship. Sponsored content may include promotional language about the company’s potential growth, products, or services. Editorial content, including editor’s picks and feature articles, may also be featured alongside paid promotions but are generated independently and are not influenced by paid compensation unless otherwise disclosed.

 

Important Regulatory Disclosures

FINRA and SEC Regulations

StockBurger LLC is not a broker-dealer or registered investment adviser, and we are not registered with the Financial Industry Regulatory Authority (FINRA) or the U.S. Securities and Exchange Commission (SEC). As such, we are not subject to the same rules or regulations that apply to entities providing financial advisory services. The information we provide is for informational and promotional purposes only and should not be considered professional financial advice.

You are strongly encouraged to seek guidance from registered financial professionals and conduct thorough due diligence before making any investment decisions.

Due Diligence and Investment Risks

Investing in any securities, including small-cap and micro-cap stocks, involves significant risks. The information provided in this communication is based on publicly available sources, market analysis, and data provided by the companies themselves. StockBurger LLC cannot guarantee the accuracy, completeness, or reliability of this information, and you should not rely solely on this material for your investment decisions.

Before investing, you should:

  • Conduct your own due diligence: Research the company’s financial health, regulatory filings, and market position independently of this advertorial.
  • Consult with licensed financial advisors: Always consult a FINRA-licensed broker or an SEC-registered investment advisor before making investment decisions.
  • Understand the risks: Investments in stocks, especially emerging growth companies like MYNZ, carry significant risk, including the potential loss of your entire investment.

 

Forward-Looking Statements and Market Uncertainty

This communication may contain forward-looking statements regarding Mainz Biomed N.V. (MYNZ). These statements are based on assumptions and projections, which involve inherent risks and uncertainties. Forward-looking statements can often be identified by terms like “expects,” “anticipates,” “believes,” “plans,” or “intends.” Any projections about MYNZ’s future performance are speculative, and actual results could differ significantly from those projected due to factors including market volatility, economic conditions, and company-specific developments.

 

No Investment Advice

Nothing in this communication should be construed as an offer, recommendation, or solicitation to buy or sell any securities. StockBurger LLC is not a licensed financial advisor, broker-dealer, or investment advisor, and we do not provide personalized investment advice. Any information or analysis provided is for informational purposes only.

We strongly encourage you to consult with a licensed financial advisor or registered broker before making any investment decisions. Investing in small-cap, micro-cap, and emerging growth companies involves significant risks, including the potential loss of principal, and you should carefully consider your risk tolerance and investment goals.

Disclaimer of Liability

StockBurger LLC assumes no responsibility for the accuracy or completeness of the information provided in this advertorial. We cannot guarantee that any forecasts or forward-looking statements will come to fruition, and any investment made based on this information is done at your own risk. StockBurger LLC disclaims any liability for investment losses or damages resulting from reliance on the information in this communication.

Compliance with the CAN-SPAM Act

StockBurger LLC adheres to all regulations under the CAN-SPAM Act of 2003. If you wish to stop receiving promotional emails from us, please click the opt-out link at the bottom of this email or contact us at info@stockburger.news to unsubscribe. We respect your privacy and take measures to ensure that your personal data is processed in compliance with our Privacy Policy.

Contact Information

 

For any inquiries regarding this advertorial or for more information about our services, please contact us at:

StockBurger LLC

1221 Brickell Ave. Ste. 900

Miami, FL 33131

Email: info@stockburger.news